Navigation Links
Cotara in Medical News

Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009

... At the same time, we advanced our bavituximab and cotara clinical trials in FY 2009 while keeping R&D c...ology platform." Mr. King continued, "Our cotara clinical program continues to advance with patient...icine 2009 Annual Meeting, further confirming that cotara specifically localizes to brain tumors at high con...

Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program

...Phase I and Phase II Clinical Trials Have Received cotara to Date, with a Good Safety Profile and Longer-Ter...patient enrollment in the final cohort of a second cotara GBM trial, a dose confirmation and dosimetry study... than 65 patients with recurrent GBM have received cotara in the current and previous clinical studies. Loc...

Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials

...fficacy trial. In patients treated in the studies, cotara appears to be safe and well tolerated, with no dos..."We are encouraged by early results from these two cotara clinical studies and look forward to presenting da...s in this trial receive an initial imaging dose of cotara before receiving the therapeutic dose. The study's...

Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial

...dly form of brain cancer. In pilot studies cotara has shown encouraging results, demonstrating a 58%...ma trials would provide a foundation for advancing cotara into Phase III trials. "Cotara has demonst...ry and dosing data being collected in ongoing U.S. cotara trials, will help us determine the optimal design ...
Cotara in Medical Technology

Data To Be Presented at ASCO Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer

...s with minimal radiation exposure to other organs. cotara is a targeted monoclonal antibody linked to a radi...a multiforme (GBM), a deadly form of brain cancer. cotara specifically targets cells at the center of brain ...study, confirming other clinical data showing that cotara appears to have a good safety profile. The...

Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India

...aging signs of anti-tumor activity seen in earlier cotara brain cancer studies," said Steven W. King, presid...ective is to confirm the maximum tolerated dose of cotara in these GBM patients. Secondary objectives includ...ts in the trial are receiving a single infusion of cotara by convection-enhanced delivery (CED), an NIH-deve...
Cotara in Biological Technology

Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine

...se, and it can produce large quantities of labeled drug product rapidly, reliably and cost-effectively. We have been using the new process to produce cotara for our ongoing brain cancer trials and can report that it works as well in clinical practice as it does in the lab. We believe it is significant tha...

Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer

... with minimal radiation exposure to other organs. cotara is a targeted monoclonal antibody linked to a radi...rst two cohorts of the study, the concentration of cotara in brain tumors was on average more than 300-fold ...al time of six months for recurrent GBM patients. cotara is currently being tested in this Phase I dose res...

Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009

...rior bavituximab cancer study and from our ongoing cotara study in glioblastoma (GBM) patients at the presti...(R) Brain Cancer Program: Peregrine advanced the cotara brain cancer program during the quarter. -- Presented data from the cotara dosing and dosimetry study at the ASCO 2008 Annual...

Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008

...tudy in HCV patients co-infected with HIV, and two cotara studies for the treatment of glioblastoma multifor...we strengthened the foundation for progress in the cotara clinical program by initiating additional sites in two ongoing trials of cotara in patients with GBM. Data was presented at the 20...

Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study

... in brain tumors, leaving healthy tissue in the body largely unaffected. The release also reported that all of the GBM patients treated to date in the cotara Phase II safety and efficacy trial have survived past the expected median survival time for relapsed GBM patients, an early but encouraging result. Th...

Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008

... distinguished brain cancer center and experienced cotara clinical study site -- the Barrow Neurological Ins...tiative to raise awareness for the bavituximab and cotara programs in the scientific and medical communities...ek of an abstract discussing patient data from the cotara dosimetry trial for presentation at the 2008 ASCO ...

Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008

...nd demonstrated encouraging signs of anti-viral activity. Cotara(R) Brain Cancer Clinical Program To help accelerate the ongoing Phase II trial of cotara in patients with glioblastoma multiforme, one of the most deadly forms of brain cancer, Peregrine recently added two new sites to the study, for a tot...
Other Tags
(Date:5/2/2015)... ProText Kinetic 2 is a set of ... Pro X. ProText Kinetic 2 features 40 animation ... Pro X . Easily create interactive text videos without ... ProText Kinetic 2. , Using ProText Kinetic is as easy ... Kinetic presets in the FCPX timeline. Playback the default ...
(Date:5/2/2015)... “ Peachtree Audio ” was featured on ... features the latest and coolest technology products available to ... for NewsWatch, conducted the review and shared with viewers ... Music is an important part of people’s lives – ... the royal treatment. Peachtree Audio does just that with ...
(Date:5/2/2015)... TX (PRWEB) May 02, 2015 ... skin laxity issues of the face, neck and ... new concept with real potential for the success ... by the ThermiHealth Clinical Advisory Council, ThermiGyn’s Women’s ... FACOG, FACS, ACGE, concluded that ThermiGyn’s temperature controlled ...
(Date:5/1/2015)... IDLife LLC, a health and wellness ... the addition of its newest partner and fitness celebrity, ... athlete, growing up in gymnastics and competitive diving, but ... a personal trainer and helping others achieve their fitness ... TV shows highlighting her stunning physique and unique training ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 Jusuru International ... for the successful repositioning of its flagship nutritional supplement, ... brand with a new name, new logo, new packaging, ... Ethos Awards are designed to identify and promote programs ... best. , “DSA congratulates Jusuru International for their ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5
(Date:4/20/2015)... 2015 Huntington Memorial Hospital is the first ... new miniaturized, wireless monitoring sensor to manage heart failure ... only FDA-approved heart failure monitoring device that has been ... physicians to manage heart failure. The CardioMEMS ... the pulmonary artery (PA) during a non-surgical procedure to ...
(Date:4/14/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... New York Design Awards under the category  ,Product Design ... Design Awards are part of a global multi-disciplinary awards ... from the marketplace, industry and judging panel. Winners will ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... April 23, 2015, after the close of market. The ... and investors at 2:00 p.m. PT (5:00 p.m. ET), ... To participate on the live call, analysts and ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2
Other Contents